scispace - formally typeset
P

Pirus Ghadjar

Researcher at Charité

Publications -  193
Citations -  4401

Pirus Ghadjar is an academic researcher from Charité. The author has contributed to research in topics: Radiation therapy & Prostate cancer. The author has an hindex of 33, co-authored 171 publications receiving 3528 citations. Previous affiliations of Pirus Ghadjar include Memorial Sloan Kettering Cancer Center & University Hospital of Bern.

Papers
More filters
Journal ArticleDOI

Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry.

TL;DR: This analysis summarises all recent clinical trials registered in the ClinicalTrials.gov registry and shows continuous interest and ongoing clinical research in the field of hyperthermia.
Journal ArticleDOI

Magnetic resonance thermometry: Methodology, pitfalls and practical solutions

TL;DR: This review summarises and discusses advances in MR thermometry, providing practical considerations, pitfalls and technical obstacles constraining temperature measurement accuracy, spatial and temporal resolution in vivo.
Journal ArticleDOI

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.

TL;DR: Results from other dose-escalation trials, meeting the inclusion criteria for the present analysis, were not included: The Medical Research Council RT01 trial reported a 5-year biochemical progression-free survival rate of 57% for 184 patients treated within the doseescalated arm after neoadjuvant ADT and the Dutch trial described a 6-year freedomfrom-failure rate of 49%, based on 179 patients from the experimental arm.
Journal ArticleDOI

The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.

TL;DR: The literature on expression patterns of CCL20 and CCR6 and their physiological interactions as well as the currently presumed role of CCR 6 and CCL 20 in the formation of colorectal cancer liver metastasis are reviewed, providing a potential basis for novel treatment strategies.